Buscar resultados de ensayos clínicos
Membranous Nephropathy - 7 Studies Found
| Estado | Estudiar |
| Active, not recruiting |
Nombre del estudio: Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients Condición:
Fecha: 2011-06-29 Intervenciones:
|
| Completed |
Nombre del estudio: Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome Condición:
Fecha: 2006-08-09 Intervenciones: Drug: tacrolimus combined with prednisone |
| Completed |
Nombre del estudio: Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy Condición: Fecha: 2025-11-04 |
| NOT_YET_RECRUITING |
Nombre del estudio: REmission in Membranous Nephropathy International Trial (REMIT) Condición: Primary Membranous Nephropathy Fecha: 2025-11-04 Intervenciones: Participants will receive an intravenous infusion of 1,000mg Obinutuzumab at Weeks 0, 2, 24 and 26.Prior to the administration of obinutuzum |
| Completed |
Nombre del estudio: A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy Condición: Primary Membranous Nephropathy Fecha: 2025-11-04 Intervenciones: Participants will receive zanubrutinib once daily |
| Completed |
Nombre del estudio: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy Condición: Primary Membranous Nephropathy Fecha: 2025-11-04 Intervenciones: Subjects will be randomly assigned in 1:1 treatment allocation ratio to receive the test and reference product. |
| COMPLETED |
Nombre del estudio: MOR202 for Refractory MN Condición: Membranous Nephropathy Fecha: 2025-11-04 Intervenciones: Each patient will be treated for 24 weeks and received a total of 9 doses.During the first treatment cycle, MOR202 will be administered weekly. |